Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01546324 · ClinicalTrials.gov registry record
Collection of Maternal Blood Samples for Development of Non-invasive Prenatal Diagnostic Testing
A clinical trial, sponsored by Natera.
- Completed
- Registry status
- 16
- Enrollment target
NCT01546324 is a clinical trial that has completed, run by Natera. The registered enrollment target is 16 participants.
The verdict
NCT01546324 has completed, sponsored by Natera.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to collect blood samples from pregnant women who achieved pregnancy following in-vitro fertilization (IVF) with Natera's preimplantation aneuploidy screening (with or without single gene gene testing). These samples will be used for test development of non-invasive prenatal diagnostic testing.
Interventions
- PROCEDURE Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01546324
The ClinicalTrials.gov registry entry for NCT01546324 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.
NCT01546324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01546324 about?
NCT01546324 is a clinical study titled "Collection of Maternal Blood Samples for Development of Non-invasive Prenatal Diagnostic Testing". The purpose of this study is to collect blood samples from pregnant women who achieved pregnancy following in-vitro fertilization (IVF) with Natera's preimplantation aneuploidy screening (with or without single gene gene testing). These samples will be used for test development of non-invasive prena...
What is the current status of trial NCT01546324?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2012-02. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01546324?
The interventions under investigation include: Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT01546324?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.